Nachrichten zur Illumina Inc. Aktie

Illumina Shares Hit a 10-Year Low as the Companys Customers Pull Back on Spending

Illumina missed revenue forecasts and cut its full-year outlook, citing "challenging" macroeconomic conditions.…

Illumina: Letzter Platz im S&P 500 - das ist der Grund

Die Aktien von Illumina schmieren regelrecht ab, nachdem das Unternehmen seine Umsatz- und Gewinnprognose für das Gesamtjahr das zweite Quartal…

Illumina: Letzter Platz im S&P 500 - das ist der Grund

Die Aktien von Illumina schmieren regelrecht ab, nachdem das Unternehmen seine Umsatz- und Gewinnprognose für das Gesamtjahr das zweite Quartal…

Illumina: Die Aktie auf dem Weg, ihr schlechtestes Jahr seit 2002 zu erleben - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Illumina-Aktienanalyse von "Der Aktionär": Fabian Strebin vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Illumina Inc. (ISIN: US4523271090,…

Stocks making the biggest moves midday: Groupon, Wynn Resorts, Plug Power, Illumina and more

These are the stocks posting the largest moves in midday trading.…

DNA-Reading Giant Crashes As Macro Pressures Guidance

Illumina expects flat growth in 2024, which lines up with other life sciences tools companies.…

: Illumina’s stock on track for lowest close in 10 years after cutting guidance

Illumina Inc.’s stock ILMN fell 14% Friday to put it on track for its lowest close in 10 years, after…

Illumina shares slip after genetic testing group lowers profit guidance By Investing.com

Illumina shares slip after genetic testing group lowers profit guidance…

Illumina stock drops on another earnings warning

Illumina Inc (NASDAQ:ILMN) shares sank 11% in pre-market trading on Friday after the gene-testing company reduced its annual profit forecast…

Wynn Resorts, Illumina, Plug Power fall premarket; Apple rises By Investing.com

Wynn Resorts, Illumina, Plug Power fall premarket; Apple rises…

Movers & Shakers: Lions Gate shares rise on surprise profit, Plug Power stock plunges on supply warning and more moving stocks

Shares in Synaptics, Lions Gate Entertainment, Plug Power, Trade Desk, Unity Software and Illumina were all active in pre market…

Illumina, Inc. (ILMN) Q3 2023 Earnings Call Transcript

…

Illumina cuts annual profit forecast for second straight quarter

(Reuters) – U.S. genetic testing Illumina on Thursday trimmed its annual profit forecast for the second straight quarter, hurt by…

Illumina cuts annual profit forecast for second straight quarter

…

Illumina cuts annual profit forecast for second straight quarter By Reuters

Illumina cuts annual profit forecast for second straight quarter…

: Illumina shares fall as company cuts forecasts

Shares of Illumina Inc. ILMN fell after hours on Thursday after the maker of DNA-sequencing technology cut its full-year sales…

Illumina plunges 8% on Q3 revenue miss & disappointing guidance By Investing.com

Illumina plunges 8% on Q3 revenue miss & disappointing guidance…

Illumin gets TSK nod to proceed with NCIB

…

Massive Kursverluste für die Illumina-Aktie (105,1119 €)

Die Aktie von Illumina zählt heute zu den großen Verlierern an der Börse. Der Titel verliert deutlich an Wert. Zu…

2028 Global Nanopore Sequencing Market Forecast with Key Players: Oxford Nanopore Technologies, Illumina, Roche, 10X Genomics, and More

Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Nanopore Sequencing Market 2018-2028" report has been added to…

Global Hereditary Testing Market Size To Worth USD 13.14 Billion By 2032 | CAGR of 7.8%

The Global Hereditary Testing Market Size was valued at USD 6.20 Billion in 2022 and the Worldwide Hereditary Testing Market…

Illumina stock hits new 52-week low amid Grail divesture woes

…

illumin Announces Date for Third Quarter 2023 Financial Results Video Conference Call

TORONTO and NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- illumin (TSX: ILLM, OTC: ILLMF) (“illumin” or “Company”),…

Das Wertpapier von Illumina läuft schlechter: Große Kursverluste! (120,3599 €)

Die Aktie von Illumina zählt heute zu den großen Verlierern an der Börse. Der Titel verbilligt sich am Mittwoch deutlich.…

Activist Icahn sues Illumina board over Grail acquisition

Activist-investor Carl Icahn said his firm had sued current and former board directors at Illumina concerning the acquisition of gene-sequencing…

Activist Icahn sues Illumina board over Grail acquisition

Activist Icahn sues Illumina board over Grail acquisition - FT…

Carl Icahn reportedly sues former Illumina CEO, board members

…

Illumina to divest Grail within a year if it does not win challenge in EU court By Reuters

Illumina to divest Grail within a year if it does not win challenge in EU court…

: Illumina responds to EC Grail divestiture order

Illumina Inc. ILMN responded Friday to an order it received Thursday from the European Commission directing the company to…

Illumina-Aktie kann sich nicht behaupten: Kurs fällt um 3,76 Prozent (126,0087 €)

Die Aktie von Illumina zählt am Donnerstag zu den großen Verlierern an der Börse. Das Wertpapier verliert deutlich an Wert.…

EU antitrust regulators order Illumina to sell Grail By Investing.com

EU antitrust regulators order Illumina to sell Grail…

Illumina ordered to divest GRAIL unit in EU

…

Illumina ordered by EU antitrust regulators to sell Grail

U.S. genetic testing company Illumina has been ordered by EU antitrust regulators to sell cancer test maker Grail after it…

Illumina ordered by EU antitrust regulators to sell Grail By Reuters

Illumina ordered by EU antitrust regulators to sell Grail…

Illumina to quickly divest Grail if it loses EU or US appeal: report

…

Illumina to divest Grail if it loses final court appeals in US or EU By Reuters

Illumina to divest Grail if it loses final court appeals in US or EU…

Guten Morgen mit Uniper, Roche, AboutYou ...

*VILLEROY/EZB: DIE ZINSSÄTZE SIND JETZT AUF DEM RICHTIGEN NIVEAUROG SW - Roche erzielt mit Augenmittel Vabysmo weiteren Behandlungserfolg ILLUMINA -…

EU regulators to order Illumina to sell Grail - Financial Times By Investing.com

EU regulators to order Illumina to sell Grail - Financial Times…

Illumina falls amid reports of an EU order to sell Grail

…

Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors

NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress…

Illumina: Kursziel gekürzt

London (www.aktiencheck.de) - Rating-Update: Die HSBC stuft die Aktie von Illumina Inc. (ISIN: US4523271090, WKN: 927079, Ticker-Symbol: ILU, NASDAQ-Symbol: ILMN) unverändert…

Global Epigenomics Market Research Report 2023-2031 Featuring Epigenomics AG, Illumina, Merck, Zymo Research, & Agilent Technologies

Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The "Global Epigenomics Market Report and Forecast 2023-2031" report has been…

Single-Cell Omics Market revenue to hit USD 30 Billion by 2035, says Research Nester

Prominent single-cell omics market players include 10x Genomics, Inc., Becton, Dickinson and Company (BD), CELLENION, PerkinElmer Inc., ANGLE plc, Illumina,…

Bernstein bullish on Thermo, Revvity, Guardant, PacBio; bearish on Illumina

…

Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors

NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress…

dpa-AFX ProFeed